The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway

American Journal of Epidemiology

Volumn 168, Issue 9, 2008, Pages 1065-1072

  Aamodt, Geir ^a,b   Bukholm, Geir ^a,c   Jahnsen, Jørgen ^d   Moum, Bjørn ^d   Vatn, Morten H ^a,e   Lygren, Idar ^f   Aubert, Erik ^g   Henriksen, Magne ^g   Flaaten, Borgar ^h   Schultz, Tom ⁱ   Sauar, Jostein ^j   Kjellevold, Øystein ^k   Stray, Njål ^l  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g Østfold Hospital   (Norway)

^h Notodden Hospital

ⁱ Sørlandet Hospital Arendal HF   (Norway)

^j TELEMARK HOSPITAL   (Norway)

^k Blefjell sykehus HF   (Norway)

^l DIAKONHJEMMET HOSPITAL   (Norway)

more..

Author keywords

Cohort studies; Colitis, ulcerative; Crohn disease; Inflammatory bowel diseases; Norway; Water supply

Indexed keywords

ALUMINUM; DRINKING WATER; IRON;

ACIDITY; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); CONFIDENCE INTERVAL; DISEASE INCIDENCE; DISEASE SEVERITY; DRINKING WATER; ENVIRONMENTAL FACTOR; ETIOLOGY; IMMUNE RESPONSE; IRON; MICROBIAL ACTIVITY; MUTATION; TURBIDITY; WATER CHEMISTRY; WATER SUPPLY;

ARTICLE; COLIFORM BACTERIUM; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; NORWAY; TURBIDITY; ULCERATIVE COLITIS; WATER QUALITY; WATER SUPPLY;

EURASIA; EUROPE; NORTHERN EUROPE; NORWAY; SCANDINAVIA;

EID: 54949098181     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn218     Document Type: Article

References (33)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641-1657.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627-1640.
3. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101(7):1559-1568.
4. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31(1):1-20.
5. Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006;12(7):641-650.
6. Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12(3):218-226.
7. Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004;127(4):1051-1057.
8. Green C, Elliott L, Beaudoin C, et al. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006;164(7):615-623.
9. Aamodt G, Jahnsen J, Bengtson MB, et al. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993. Inflamm Bowel Dis. 2008;14(7):984-991.
10. Chamberlin WM, Naser SA. Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit. 2006;12(2):RA27-RA33.
11. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007;132(4):1359-1374.
12. Perl DP, Fogarty U, Harpaz N, et al. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis. 2004;10(6):881-883.
13. Lerner A. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis. Ann N Y Acad Sci. 2007;1107:329-345.
14. Fogarty U, Perl D, Good P, et al. A cluster of equine granulomatous enteritis cases: the link with aluminum. Vet Hum Toxicol. 1998;40(5):297-305.
15. Ganrot PO. Aluminum: possible etiologic agent in Crohn's disease? In: Jarnerot G, ed. Inflammatory Bowel Disease. New York, NY: Raven Press; 1987:119-128.
16. Delaney JC, Smeester L, Wong CY, et al. AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. Nat Struct Mol Biol. 2005;12(10):855-860.
17. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci. 1996;41(10):2078-2086.
18. Abubakar I, Myhill DJ, Hart AR, et al. A case-control study of drinking water and dairy products in Crohn's disease - further investigation of the possible role of Mycobacterium avium paratuberculosis. Am J Epidemiol. 2007;165(7):776-783.
19. Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93 - a prospective population-based study. Scand J Gastroenterol. 1996;31(4):355-361.
20. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93 - a prospective population-based study. Scand J Gastroenterol. 1996;31(4):362-366.
21. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
22. Henriksen M, Jahnsen J, Lygren I, et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41(9):1037-1043.
23. World Health Organization. Guidelines for Drinking-water Quality. Geneva, Switzerland: World Health Organization; 2004.
24. Cressie NAC. Statistics for Spatial Data. New York, NY: Wiley & Sons, Inc; 1993.
25. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 2007;52(9):2015-2021.
26. Spitz DR, Azzam EI, Li JJ, et al. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev. 2004;23(3-4):311-322.
27. Erichsen K, Hausken T, Ulvik RJ, et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol. 2003;38(5):543-548.
28. Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol. 2005;40(9):1058-1065.
29. Seril DN, Liao J, West AB, et al. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. J Clin Gastroenterol. 2006;40(5):391-397.
30. Wooldridge KG, Williams PH. Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol Rev. 1993;12(4):325-348.
31. Grandjean D, Jorand F, Guilloteau H, et al. Iron uptake is essential for Escherichia coli survival in drinking water. Lett Appl Microbiol. 2006;43(1):111-117.
32. Hantke K. Iron and metal regulation in bacteria. Curr Opin Microbiol. 2001;4(2):172-177.
33. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122(1):44-54.